Biphenyl vasopressin agonists
    5.
    发明申请

    公开(公告)号:US20060276456A1

    公开(公告)日:2006-12-07

    申请号:US11502982

    申请日:2006-08-11

    IPC分类号: A61K31/551 C07D487/02

    摘要: A compound of the formulae (I) or (II): wherein: Y is a moiety selected from NR or —(CH2)n; wherein R is hydrogen or (C1-C6) lower alkyl, and n is 1; represents: (1) a phenyl ring optionally substituted with one or two substituents selected, independently, from the group comprising hydrogen, (C1-C6) lower alkyl, halogen, cyano, CF3, hydroxy, (C1-C6) lower alkoxy, (C1-C6) lower alkoxy carbonyl, carboxy, —CONH2, —CONH[(C1-C6) lower alkyl], —CON[(C1-C6) lower alkyl]2; or (2) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, halogen or (C1-C6) lower alkoxy; represents: (1) a phenyl ring optionally substituted with one or two substituents selected, independently, from the group comprising hydrogen, (C1-C6) lower alkyl, halogen, cyano, CF3, hydroxy, (C1-C6) lower alkoxy, or (C1-C6) lower alkoxy carbonyl, carboxy, —CONH2, —CONH[(C1-C6) lower alkyl], —CON[(C1-C6) lower alkyl]2; or (2) a 5-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, (C1-C6) lower alkoxy, or halogen; or (3) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, halogen, or (C1-C6) lower alkoxy; represents a 5-membered aromatic (unsaturated) heterocyclic ring having one sulfur atom, optionally substituted by (C1-C6) lower alkyl, halogen, or (C1-C6) lower alkoxy; R1 is a moiety of the formula and R2, R3, R7, R8 and R9 are, independently, selected from a group consisting of hydrogen, (C1-C3) lower alkyl, OCH3, halogen, CF3, —SCH3, OCF3, SCF3, or CN; or a pharmaceutically acceptable salt, or pro-drug form thereof.

    Biphenyl vasopressin agonists
    8.
    发明申请
    Biphenyl vasopressin agonists 失效
    联苯加压素激动剂

    公开(公告)号:US20050075328A1

    公开(公告)日:2005-04-07

    申请号:US10980939

    申请日:2004-11-04

    摘要: A compound of the formulae (I) or (II): wherein: Y is a moiety selected from NR or —(CH2)n; wherein R is hydrogen or (C1-C6) lower alkyl, and n is 1; represents: (1) a phenyl ring optionally substituted with one or two substituents selected, independently, from the group comprising hydrogen, (C1-C6) lower alkyl, halogen, cyano, CF3, hydroxy, (C1-C6) lower alkoxy, (C1-C6) lower alkoxy carbonyl, carboxy, —CONH2, —CONH[(C1-C6) lower alkyl], —CON[(C1-C6) lower alkyl]2; or (2) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, halogen or (C1-C6) lower alkoxy; represents: (1) a phenyl ring optionally substituted with one or two substituents selected, independently, from the group comprising hydrogen, (C1-C6) lower alkyl, halogen, cyano, CF3, hydroxy, (C1-C6) lower alkoxy, or (C1-C6) lower alkoxy carbonyl, carboxy, —CONH2, —CONH[(C1-C6) lower alkyl], —CON[(C1-C6) lower alkyl]2; or (2) a 5-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, (C1-C6) lower alkoxy, or halogen; or (3) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C1-C6) lower alkyl, halogen, or (C1-C6) lower alkoxy; represents a 5-membered aromatic (unsaturated) heterocyclic ring having one sulfur atom, optionally substituted by (C1-C6) lower alkyl, halogen, or (C1-C6) lower alkoxy; R1 is a moiety of the formula and R2, R3, R7, R8 and R9 are, independently, selected from a group consisting of hydrogen, (C1-C3) lower alkyl, OCH3, halogen, CF3, —SCH3, OCF3, SCF3, or CN; or a pharmaceutically acceptable salt, or pro-drug form thereof.

    摘要翻译: 式(I)或(II)的化合物:其中:Y是选自NR或 - (CH 2)n的部分; 其中R是氢或(C1-C6)低级烷基,n是1; (C1-C6)低级烷基,卤素,氰基,CF3,羟基,(C1-C6)低级烷氧基,(C1-C6)低级烷氧基,(C1-C6)低级烷氧基,(C1-C6) C 1 -C 6低级烷氧基羰基,羧基-CONH 2,-CONH [(C 1 -C 6)低级烷基],-CON [(C 1 -C 6)低级烷基] 或(2)任选被(C 1 -C 6)低级烷基,卤素或(C 1 -C 6)低级烷氧基取代的具有一个氮原子的6元芳族(不饱和)杂环; 表示:(1)任选被一个或两个取代基取代的苯环,所述取代基独立地选自氢,(C 1 -C 6)低级烷基,卤素,氰基,CF 3,羟基,(C 1 -C 6)低级烷氧基或 (C 1 -C 6)低级烷氧基羰基,羧基,-CONH 2,-CONH [(C 1 -C 6)低级烷基],-CON [(C 1 -C 6)低级烷基] 或(2)任选被(C 1 -C 6)低级烷基,(C 1 -C 6)低级烷氧基或卤素取代的具有一个氮原子的5元芳族(不饱和)杂环; 或(3)具有一个氮原子,任选被(C 1 -C 6)低级烷基,卤素或(C 1 -C 6)低级烷氧基取代的6元芳族(不饱和)杂环; 表示任选被(C 1 -C 6)低级烷基,卤素或(C 1 -C 6)低级烷氧基取代的具有一个硫原子的5元芳族(不饱和)杂环; R 1是下式的部分,R 2,R 3,R 7,R 8和R 9独立地选自氢

    N-Substituted cyclopeptide derivatives
    9.
    发明授权
    N-Substituted cyclopeptide derivatives 失效
    N-取代的环肽衍生物

    公开(公告)号:US4351828A

    公开(公告)日:1982-09-28

    申请号:US164663

    申请日:1980-06-30

    IPC分类号: A61K38/00 C07K7/64 A61K37/00

    摘要: The N-substituted cyclopeptide derivatives of formula I ##STR1## in which R.sup.1 is lower alkyl, R.sup.2 is lower alkyl or cyclo(lower)alkyl, R.sup.3 is a neutral amino acid side chain and Y is a peptide residue having three to nine amino acid residues and a method for the preparation of the compounds of formula I are disclosed. The compounds of formula I are useful antibacterial and antifungal agents. Pharmaceutical compositions also are disclosed.

    摘要翻译: 式I的N-取代的环肽衍生物,其中R 1是低级烷基,R 2是低级烷基或环(低级)烷基,R 3是中性氨基酸侧链,Y是一个肽残基, 公开了9个氨基酸残基和制备式I化合物的方法。 式I的化合物是有用的抗菌和抗真菌剂。 也公开了药物组合物。